Hiroshige Yoshioka

15PUBLICATIONS
75CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 14, 2026
Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in Japan.

|Apr 21, 2026
Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J-TAIL-2.

|Dec 11, 2025
Atezolizumab + Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2).

Hiroshige Yoshioka, Makoto Nishio, Kadoaki Ohashi

|Apr 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.

Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi

|Mar 17, 2025
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study.

Fumihiko Kinoshita, Shigeru Tanzawa, Toshihiro Misumi

|Feb 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.

Shigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi

Pageof 3

Frequent Collaborators

4 joint publications

Takayasu Kurata

3 joint publications

Akihiko Gemma

3 joint publications

Makoto Nishio

3 joint publications

Kadoaki Ohashi